The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Projected To Become By 2030 Based On Its 2026 Valuation?
The market for arrayed clustered regularly interspaced short palindromic repeats (crispr) screening has experienced rapid expansion over recent years. This market is projected to expand from $1.52 billion in 2025 to $1.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.5%. Historically, this growth can be ascribed to factors such as the expansion of functional genomics research, the availability of crispr editing reagents, the growth of academic screening programs, the early adoption of arrayed screening formats, and the increasing use of cell-based assays.
The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $3.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.7%. Key drivers for this growth during the projection period include the escalating demand for precise drug discovery, augmented investments in gene therapy research, the broadening scope of disease modeling applications, the expanding adoption of bioinformatics-powered screening methods, and strengthened partnerships between academic institutions and industry. Noteworthy trends expected over the forecast period encompass a heightened need for targeted gene validation screens, increased utilization of high-throughput arrayed crispr assays, deeper integration of phenotypic data analytics, the proliferation of customized crispr screening offerings, and a sharpened emphasis on the accuracy of functional genomics.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33018&type=smp
Which Market Drivers Are Supporting The Expansion Of The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
The arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market is anticipated to expand due to the growing emphasis on personalized medicine. Personalized medicine customizes treatment and prevention strategies to an individual’s unique genetic, biological, and lifestyle characteristics. Its adoption is rising, driven by advancements in genomics and molecular diagnostics that enable treatments to be tailored for improved patient outcomes. Arrayed CRISPR screening supports personalized medicine by systematically evaluating the impact of specific gene modifications on individual cell responses, thereby assisting in identifying patient-specific drug targets, forecasting treatment efficacy, and developing bespoke therapies based on a person’s genetic and cellular makeup. A relevant example occurred in February 2024, when the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. These newly sanctioned personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the heightened focus on personalized medicine is a key factor propelling the growth of the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market. The arrayed CRISPR screening market is projected to grow as the occurrence of genetic diseases becomes more widespread. Genetic diseases involve disorders resulting from defects or changes in an individual’s genes or chromosomes, which impair normal bodily functions. The incidence of these conditions is increasing, partly due to advanced parental age, which elevates the likelihood of mutations and chromosomal abnormalities in children. Arrayed CRISPR screening supports genetic disease research by allowing individual genes to be tested to identify those responsible for the illness, thereby accelerating the creation of targeted treatments. For instance, in October 2024, the Cystic Fibrosis Trust, a UK-based charity assisting individuals with cystic fibrosis, reported that the number of registered cystic fibrosis (a genetic disorder) patients rose from around 11,148 in 2022 to 11,318 in 2023, indicating a 1.5% increase in patient registrations year over year. Thus, the escalating prevalence of genetic diseases is a significant factor fueling the expansion of the arrayed CRISPR screening market.
What Segment Groups Are Identified Within The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market covered in this report is segmented –
1) By Product Type: Clustered Regularly Interspaced Short Palindromic Repeats Libraries; Reagents And Consumables; Instruments; Software And Services
2) By Application: Functional Genomics; Drug Discovery; Disease Modeling; Gene Validation; Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End Users
Subsegments:
1) By Clustered Regularly Interspaced Short Palindromic Repeats Libraries: Genome Wide Knockout Libraries; Targeted Gene Libraries; Activation Libraries; Repression Libraries; Custom Designed Libraries
2) By Reagents And Consumables: Guide Ribonucleic Acid Reagents; Cas Enzyme Reagents; Transfection Reagents; Cell Culture Reagents; Assay And Detection Reagents
3) By Instruments: Automated Liquid Handling Systems; High Throughput Screening Systems; Cell Imaging Systems; Flow Cytometry Instruments; Genomic Analysis Instruments
4) By Software And Services: Screening Design Software; Data Analysis Software; Bioinformatics Services; Screening Execution Services; Custom Assay Development Services
What Trends Are Advancing Progress In The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
Leading firms within the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market are increasingly forming strategic partnerships to improve the accuracy of high-throughput phenotypic screening. Such partnerships represent formal collaborations where entities merge resources, expertise, or technologies to attain common goals, thereby fostering faster innovation, mitigating risks, and expanding market presence without necessitating mergers or acquisitions. For example, in November 2023, AstraZeneca Plc, a UK-based science-focused biopharmaceutical corporation, collaborated with the UK’s Medical Research Council (MRC) and the Milner Therapeutics Institute (MTI) at the University of Cambridge, a UK biomedical research body, to establish a cutting-edge Functional Genomics Screening Laboratory (FGSL) aimed at accelerating drug discovery. This facility is dedicated to identifying gene-phenotype relationships in chronic ailments like cardiovascular and metabolic disorders, thereby bolstering the UK’s genomics leadership through open academic collaborations. Key advantages involve automated high-throughput capabilities for precise imaging and phenotyping in organoids or iPSCs, which surpass traditional pooled methodologies; additional benefits include providing free access for researchers, expediting target validation, and sharing expertise to accelerate the development of new therapies.
Which Companies Hold Significant Positions In The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
Major companies operating in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market are Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc, Applied Biological Materials Inc, Agilent Technologies Inc, Charles River Laboratories International Inc, Integrated DNA Technologies Inc, GenScript Biotech Corporation, Synthego Holdings LLC, Santa Cruz Biotechnology Inc, Creative Biolabs Inc, VectorBuilder Inc, Admera Health LLC, Addgene Inc, Ncardia, BioCat GmbH, Cellecta Inc, GeneCopoeia Inc, Creative Biogene Inc, and Aelian Biotechnology.
Read the full arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market report here:
Which Region Is Expected To Experience The Fastest Growth In The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
North America was the largest region in the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33018&type=smp
Browse Through More Reports Similar to the Global Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market 2026, By The Business Research Company
Crispr Technology Market 2026
https://www.thebusinessresearchcompany.com/report/crispr-technology-market
Crispr Gene Editing Market Report 2026
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report
Crispr And Cas Gene Market Report 2026
https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model